IP Library Granted Patent US 9,593,325
Granted Patent B2
US 9,593,325 · App. 14/171,157 · Granted Mar 14, 2017

Stable lysis buffer mixture for extracting nucleic acids

Inventors: Peter Bendzko (Berlin, DE); Hans Joos (Berlin, DE)
Assignee: STRATEC BIOMEDICAL AG
C12N9/96C12N9/2462C12N9/6424C12N15/1003C12N15/1013C12N15/1017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,593,325
App. No.
14/171,157
Granted
Mar 14, 2017
Kind
B2
Abstract

Embodiments relate to a lysis buffer mixture that is stable in storage for isolating nucleic acids from biological, preferably diagnostic samples. The mixture is preferably associated with an extraction control. The aim of the invention is to provide an improved nucleic acid extraction system, which is cost-effective, stable and easy to use, thus fulfilling the requirements of a modern nucleic acid extraction system and containing, among other things, extraction controls. Embodiments relate to a lysis buffer mixture for isolating nucleic acids, said mixture containing non chaotropic salts, a special selection of detergents, a defined quantity of at least one nucleic acid as an extraction control, optionally lytic enzymes, optionally carrier nucleic acids and optionally other additives.

Claims (19)

1. A method for preparing storage-stable, freeze-dried lysis buffer mixture for the isolation of nucleic acids from arbitrary complex initial substances, wherein said method comprises individual preparation of a first aqueous stem solution and a second aqueous stem solution, which are then mixed with one another, followed by mechanically portioning and freeze drying, wherein said first aqueous stem solution contains a mixture of at least one non-chaotropic salt, Tris, at least one detergent and at least one lytic enzyme, and wherein said second aqueous stem solution contains a nucleic acid for extraction control, carrier nucleic acids, sugar, and Tris-HCl.

2. The method of preparing the lysis buffer mixture of claim 1 , wherein the non-chaotropic salts of said first aqueous stem solution contain cations selected from the group consisting of monovalent cations, bivalent cations, multivalent cations, and mixtures thereof.

3. The method of preparing the lysis buffer mixture of claim 2 wherein the cations are selected from the group consisting of ammonium ions, sodium ions, potassium ions, magnesium ions, calcium ions, zinc ions and manganese ions.

4. The method of preparing the lysis buffer mixture of claim 1 , wherein the pH value of the lysis buffer mixture is set between 5 and 9 when in aqueous solution prior to being freeze-dried.

5. The method of preparing the lysis buffer mixture of claim 1 wherein the at least one detergent of said first aqueous stem solution is selected from the group consisting of cetyltrimethylammonium bromide, Tween 20, Triton X-100, and sodium dodecyl sulfate.

6. The method of preparing the lysis buffer mixture of claim 1 , wherein the at least one detergent of said first aqueous stem solution is cetyltrimethylammonium bromide.

7. The method of preparing the lysis buffer mixture of claim 1 , wherein the at least one detergent of said first aqueous stem solution is present in the range of 0.1-5% of the total quantity.

8. The method of preparing the lysis buffer mixture of claim 1 , wherein cetyltrimethylammonium bromide (CTAB) of said first aqueous stem solution is present as 2% of the total quantity.

9. The method of preparing the lysis buffer mixture of claim 1 , wherein the defined quantity of at least one nucleic acid as an extraction control of said second aqueous stem solution is selected from the group consisting of a synthetic nucleic acid, a nucleic acid manufactured via molecular biology methods, and a native nucleic acid.

10. The method of preparing the lysis buffer mixture of claim 1 , wherein the defined quantity of at least one nucleic acid for extraction control of said second aqueous stem solution is selected from the group consisting of at least one DNA, at least one RNA, and mixtures of at least one DNA and at least one RNA.

11. The method of preparing the lysis buffer mixture of claim 1 , wherein the at least one lytic enzymes of said first aqueous stem solution are proteinases.

12. The method of preparing the lysis buffer mixture of claim 1 , wherein the at least one lytic enzymes of said first aqueous stem solution are proteinase K.

13. The method of preparing the lysis buffer mixture of claim 1 , comprising lytic enzymes, wherein the at least one lytic enzymes of said first aqueous stem solution are proteinase K and lysozyme.

14. The method of preparing the lysis buffer mixture of claim 1 , wherein the carrier nucleic acids of said second aqueous stem solution are synthetic nucleic acids or isolates from biological materials.

15. The method of preparing the lysis buffer mixture of claim 1 , wherein the carrier nucleic acids of said second aqueous stem solution are poly A RNA, tRNA, salmon sperm DNA, or herring sperm DNA.

16. The method of preparing the lysis buffer mixture of claim 1 , wherein the lysis buffer mixture is prepared as a solid, storage-stable formulation in ready-to-use reaction vessels.

17. The method of preparing the lysis buffer mixture of claim 16 , wherein the ready-to-use reaction vessels are 96 well microtitre plates, 384 well microtitre plates, or 0.5-5 ml reaction vessels.

18. The method of preparing the lysis buffer mixture of claim 16 , wherein the ready-to-use reaction vessels are 2 ml reaction vessels.

19. The method of preparing the lysis buffer mixture of claim 1 , wherein the lysis buffer mixture is prepared in a tablet form.

Assignments (4)
CHANGE OF NAME Recorded Feb 9, 2022
From: STRATEC MOLECULAR GMBH
To: INVITEK MOLECULAR GMBH
Reel/Frame 059496/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2021
From: STRATEC SE
To: STRATEC MOLECULAR GMBH
Reel/Frame 057791/0047 →
CHANGE OF NAME Recorded Mar 14, 2019
From: STRATEC BIOMEDICAL AG
To: STRATEC SE
Reel/Frame 048595/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2014
From: BENDZKO, PETER; JOOS, HANS
To: STRATEC BIOMEDICAL AG
Reel/Frame 032957/0761 →
Priority Claims (1)
DE 10 2008 020 258 · Apr 22, 2008 · national
Continuity (2)
Continuation 12988906
Related Publication 20140154776A1 · Jun 5, 2014